Key Highlights
- Citi launched coverage of Rocket Lab (RKLB) with a Buy rating and set a $105 price target, suggesting 51% potential upside.
- Citi’s John Godyn characterized RKLB as a “core holding for space bulls.”
- Shares of RKLB jumped approximately 3% during Thursday’s opening session after the rating and contract news.
- The company announced a 20-launch agreement with Synspective, marking its biggest commercial Electron contract to date.
- Rocket Lab’s mission backlog has now surpassed 100 launches following recent agreements.
Shares of Rocket Lab (RKLB) advanced roughly 3% when Thursday’s trading session began. The uptick came on the heels of a positive initiation from Citi alongside the disclosure of a substantial new contract.
John Godyn, an analyst at Citi, initiated coverage of RKLB shares with a Buy recommendation and established a $105 price objective. This target represents approximately 51% potential appreciation from the stock’s previous close.
Godyn characterized Rocket Lab as essential portfolio material for investors bullish on the space sector. His thesis emphasized the company’s dual presence in both launch operations and spacecraft manufacturing.
The company maintains operations across multiple segments of the space industry. These span rocket launches, satellite components, and ground infrastructure for launch operations.
Analyst Emphasizes Electron Success and Business Model
According to Godyn, Rocket Lab stands among the rare companies delivering consistent commercial orbital access. He cited the Electron launch vehicle as evidence of this operational capability.
The Citi analyst also emphasized Rocket Lab’s vertically integrated approach. This structure enables the company to capture revenue across multiple value chains rather than relying solely on launch services.
The Citi coverage initiation coincided with Rocket Lab revealing its largest commercial Electron contract. The company finalized a multi-year arrangement with Synspective, a Tokyo-based Earth observation company.
This arrangement encompasses 20 Electron missions. Rocket Lab will place Synspective’s StriX synthetic aperture radar satellites into sun-synchronous orbit.
The launches are planned to occur from 2028 through 2031. All missions will lift off from Rocket Lab’s Launch Complex 1 facility located in New Zealand.
Mission Backlog Crosses 100-Launch Threshold
This latest agreement elevates Synspective’s total reserved Electron launches to 47. This positions Synspective as Rocket Lab’s most significant customer measured by mission volume.
According to Rocket Lab, this contract along with additional multi-launch arrangements signed during the current year has elevated its total launch manifest beyond 100 missions. This provides enhanced long-term revenue visibility for the Electron program.
Peter Beck, Rocket Lab’s founder and CEO, offered remarks on the agreement. He explained that satellite operators seeking greater mission control frequently select Rocket Lab as their provider.
Beck mentioned that Synspective ranked among Electron’s initial customers. He stated the expanded partnership demonstrates trust in Electron’s launch cadence and orbital precision.
Meanwhile, Rocket Lab continues development of Neutron, its larger reusable launch vehicle, as Electron maintains consistent commercial operations. Both programs are advancing simultaneously rather than sequentially.
Data from TipRanks shows RKLB holds a Strong Buy consensus rating. This assessment reflects 14 Buy recommendations and two Hold recommendations issued during the last three months.
The consensus analyst price target for Rocket Lab stands at $110.07. This projection indicates approximately 56% upside potential from present levels, modestly above Citi’s stated target.
Neither Rocket Lab nor Synspective revealed the financial terms associated with their agreement.


